Stryker Corporation

$SYK - NYSE - Healthcare Equipment/Supplies
ON 0


Up 0 0 Down
Stryker to Host Conference Call on April 23, 2014

Kalamazoo, Michigan - March 24, 2014 - Stryker Corporation (NYSE:SYK) announced
that it will host a conference call on Wednesday, April 23, 2014 at 4:30 p.m.,
Eastern Time, to discuss the Company's operating results for the quarter ended
March 31, 2014 and provide an operational update. Final operating results for
the quarter ended March 31, 2014 will be released at 4:00 p.m. that day.
To participate in the conference call dial (800) 708-4540 (domestic) or (847)
619-6397 (international) and be prepared to provide confirmation number
36936589 to the operator.

A simultaneous webcast of the call will be accessible via the Company's website
at The call will be archived on this site for 90 days.

A recording of the call will also be available from 8:00 p.m., Eastern Time, on
Wednesday, April 23, 2014, until 11:59 p.m., Eastern Time, on Wednesday, April
30, 2014. To hear this recording you may dial (888) 843-7419 (domestic) or
630-652-3042 (international) and enter the passcode 36936589 #.

Forward-Looking Statements

This press release contains information that includes or is based on forward-
looking statements within the meaning of the federal securities law that are
subject to various risks and uncertainties that could cause our actual results
to differ materially from those expressed or implied in such statements. Such
factors include, but are not limited to: weakening of economic conditions that
could adversely affect the level of demand for our products; pricing pressures
generally, including cost-containment measures that could adversely affect the
price of or demand for our products; changes in foreign exchange markets;
legislative and regulatory actions; unanticipated issues arising in connection
with clinical studies and otherwise that affect U.S. Food and Drug
Administration approval of new products; changes in reimbursement levels from
third-party payors; a significant increase in product liability claims; the
ultimate total cost with respect to the Rejuvenate and ABG II matter; the impact
of investigative and legal proceedings and compliance risks; resolution of tax
audits; the impact of the federal legislation to reform the United States
healthcare system; changes in financial markets; changes in the competitive
environment; our ability to integrate acquisitions; and our ability to realize
anticipated cost savings as a result of workforce reductions and other
restructuring activities. Additional information concerning these and other
factors is contained in our filings with the U.S. Securities and Exchange
Commission, including our Annual Report on Form 10-K and Quarterly Reports on
Form 10-Q.

Stryker is one of the world's leading medical technology companies and together
with our customers, we are driven to make healthcare better. The Company offers
a diverse array of innovative medical technologies, including reconstructive,
medical and surgical, and neurotechnology and spine products to help people lead
more active and more satisfying lives. Stryker products and services are
available in over 100 countries around the world. Please contact us for more
information at


For investor inquiries please contact:
Katherine A. Owen, Stryker Corporation, 269-385-2600 or

This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
    other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
     originality of the information contained therein.

Source: Stryker Corporation via GlobeNewswire

SHARE THIS: Twitter StockTwits LinkedIn Google Plus SHORT URL: